Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Implants / Devices
    • Siemens plans to float...

    Siemens plans to float Healthineers in first half of 2018

    Written by Ruby Khatun Khatun Published On 2018-02-21T09:45:05+05:30  |  Updated On 21 Feb 2018 9:45 AM IST
    Siemens plans to float Healthineers in first half of 2018

    Frankfurt: Industrial giant Siemens said it plans to list its Healthineers medical unit in the first half of 2018, in what is expected to be Germany's largest initial public offering in over two decades.


    The group said it would float "a meaningful minority share" in the medical equipment division on the Frankfurt stock exchange to "create a liquid market for the Siemens Healthineers shares".


    The IPO "is expected to be completed in the first half of calendar year 2018, subject to capital market conditions," it said in a statement.


    German media have speculated that Siemens will sell off a 15-to-25 percent stake in Healthineers.


    They have described the flotation, expected to raise some nine billion euros ($11.2 billion), as the country's largest since Deutsche Telekom's roughly 10-billion-euro IPO in 1996.


    Siemens gave no such details in its statement, saying only that it will "retain a majority stake in Siemens Healthineers in the long term".


    "Siemens Healthineers is now ready for its market debut," said Michael Sen, a member of the Siemens managing board.


    Healthineers, which makes medical devices such as X-ray machines and lab diagnostics gear, is one of Siemens' largest and most profitable divisions and a leading player worldwide in the industry.


    The division saw revenues of 13.8 billion euros in the 2017 fiscal year, booking adjusted profits of 2.5 billion euros -- giving it a profit margin of some 18 percent, according to the statement.

    capital marketHealthineers medical unitinitial public offeringIPOmedical equipmentMichael SenSiemensSiemens Healthineers
    Source : AFP

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok